These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 29057512)

  • 1. Induction of porcine-specific regulatory T cells with high specificity and expression of IL-10 and TGF-β1 using baboon-derived tolerogenic dendritic cells.
    Li M; Eckl J; Abicht JM; Mayr T; Reichart B; Schendel DJ; Pohla H
    Xenotransplantation; 2018 Jan; 25(1):. PubMed ID: 29057512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel and effective method to generate human porcine-specific regulatory T cells with high expression of IL-10, TGF-β1 and IL-35.
    Li M; Eckl J; Geiger C; Schendel DJ; Pohla H
    Sci Rep; 2017 Jun; 7(1):3974. PubMed ID: 28638110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ex-vivo expanded baboon CD4+ CD25 Hi Treg cells suppress baboon anti-pig T and B cell immune response.
    Singh AK; Seavey CN; Horvath KA; Mohiuddin MM
    Xenotransplantation; 2012; 19(2):102-11. PubMed ID: 22497512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and expansion of baboon CD4+CD25+ Treg cells for potential use in a non-human primate xenotransplantation model.
    Porter CM; Horvath-Arcidiacono JA; Singh AK; Horvath KA; Bloom ET; Mohiuddin MM
    Xenotransplantation; 2007 Jul; 14(4):298-308. PubMed ID: 17669171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ex vivo-expanded baboon CD39 +  regulatory T cells prevent rejection of porcine islet xenografts in NOD-SCID IL-2rγ
    Huang D; Wang Y; Hawthorne WJ; Hu M; Hawkes J; Burns H; Davies S; Gao F; Chew YV; Yi S; O'Connell PJ
    Xenotransplantation; 2017 Nov; 24(6):. PubMed ID: 28963731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerogenic dendritic cells generated with dexamethasone and vitamin D3 regulate rheumatoid arthritis CD4
    Anderson AE; Swan DJ; Wong OY; Buck M; Eltherington O; Harry RA; Patterson AM; Pratt AG; Reynolds G; Doran JP; Kirby JA; Isaacs JD; Hilkens CM
    Clin Exp Immunol; 2017 Jan; 187(1):113-123. PubMed ID: 27667787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment.
    Strauss L; Bergmann C; Szczepanski M; Gooding W; Johnson JT; Whiteside TL
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4345-54. PubMed ID: 17671115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapamycin promotes the enrichment of CD4(+)CD25(hi)FoxP3(+) T regulatory cells from naïve CD4(+) T cells of baboon that suppress antiporcine xenogenic response in vitro.
    Singh AK; Horvath KA; Mohiuddin MM
    Transplant Proc; 2009; 41(1):418-21. PubMed ID: 19249569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic immune tuning in renal cell carcinoma: favorable prognostic impact of TGF-β1 mRNA expression in peripheral blood mononuclear cells.
    Busse A; Asemissen A; Nonnenmacher A; Ochsenreither S; Fusi A; Braun F; Stather D; Schmittel A; Miller K; Thiel E; Keilholz U
    J Immunother; 2011 Jan; 34(1):113-9. PubMed ID: 21150720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Third-party tolerogenic dendritic cells reduce allo-reactivity in vitro and ameliorate the severity of acute graft-versus-host disease in allo-bone marrow transplantation.
    Yang J; Li R; Ren Y; Yang Y; Xie R; Fan H
    Scand J Immunol; 2013 Dec; 78(6):486-96. PubMed ID: 24283771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophil elastase treated dendritic cells promote the generation of CD4(+)FOXP3(+) regulatory T cells in vitro.
    Tateosian NL; Reiteri RM; Amiano NO; Costa MJ; Villalonga X; Guerrieri D; Maffía PC
    Cell Immunol; 2011; 269(2):128-34. PubMed ID: 21477798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
    Pyzik M; Piccirillo CA
    J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4+CD25
    Singh AK; Chan JL; Seavey CN; Corcoran PC; Hoyt RF; Lewis BGT; Thomas ML; Ayares DL; Horvath KA; Mohiuddin MM
    Xenotransplantation; 2018 Mar; 25(2):e12379. PubMed ID: 29250828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestine-derived Clostridium leptum induces murine tolerogenic dendritic cells and regulatory T cells in vitro.
    Li YN; Huang F; Cheng HJ; Li SY; Liu L; Wang LY
    Hum Immunol; 2014 Dec; 75(12):1232-8. PubMed ID: 25300998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.
    Ahn JS; Krishnadas DK; Agrawal B
    Int Immunol; 2007 Mar; 19(3):227-37. PubMed ID: 17289657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective expansion of foxp3-positive regulatory T cells and immunosuppression by suppressors of cytokine signaling 3-deficient dendritic cells.
    Matsumura Y; Kobayashi T; Ichiyama K; Yoshida R; Hashimoto M; Takimoto T; Tanaka K; Chinen T; Shichita T; Wyss-Coray T; Sato K; Yoshimura A
    J Immunol; 2007 Aug; 179(4):2170-9. PubMed ID: 17675476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokines affecting CD4(+) T regulatory cells in transplant tolerance. Interleukin-4 does not maintain alloantigen specific CD4(+)CD25(+) Treg.
    Plain KM; Verma ND; Tran GT; Nomura M; Boyd R; Robinson CM; Hodgkinson SJ; Hall BM
    Transpl Immunol; 2013 Dec; 29(1-4):51-9. PubMed ID: 24139939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulating the expression of CD80/CD86 on dendritic cells to induce immune tolerance after xeno-islet transplantation.
    Ke N; Su A; Huang W; Szatmary P; Zhang Z
    Immunobiology; 2016 Jul; 221(7):803-12. PubMed ID: 26879762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGF-beta1 production by CD4+ CD25+ regulatory T cells is not essential for suppression of intestinal inflammation.
    Kullberg MC; Hay V; Cheever AW; Mamura M; Sher A; Letterio JJ; Shevach EM; Piccirillo CA
    Eur J Immunol; 2005 Oct; 35(10):2886-95. PubMed ID: 16180248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced suppression of the xenogeneic T-cell response in vitro by xenoantigen stimulated and expanded regulatory T cells.
    Jin X; Wang Y; Hawthorne WJ; Hu M; Yi S; O'Connell P
    Transplantation; 2014 Jan; 97(1):30-8. PubMed ID: 24092378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.